Abcam establishes a direct service for ANZ


Wednesday, 20 August, 2014

Protein research tool provider Abcam has established a direct service to Australia and New Zealand. Researchers can now source products and technical support directly from the UK-based company, rather than through distributors.

Abcam manufactures high-performance products such as primary and secondary antibodies, biochemicals, proteins, peptides, lysates and immunoassays. In addition, the company offers technical support and up-to-date datasheets. Such support will now be offered directly to ANZ customers, as will improved product delivery times.

“I’m delighted that we can offer an enhanced service to our customers in Australia and New Zealand,” said Abcam Commercial Director Philippe Cotrel.

“A direct service will enable us to develop closer relationships with our customers and ensure we are fully meeting their research needs.”

Related News

Existing medicines could help treat deadly childhood dementia

Australian researchers have identified several existing TGA‑approved medicines that could help...

Statins reduce heart attack and stroke risk in older people

It has previously been unclear whether statins were effective in reducing heart attack and stroke...

Heart muscle regeneration genes mapped

Researchers have uncovered insights into how stem cells develop and mature into heart muscle...


  • All content Copyright © 2026 Westwick-Farrow Pty Ltd